Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Mar 15, 2025; 17(3): 101174
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.101174
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.101174
Figure 6 Detection of HepG2 and Huh7 cell viability.
A: Statistical chart showing the survival rates of HepG2 cells treated with tetrahydrocurcumin (THC) for 24, 48, and 72 hours; B: The survival rate of Huh7 cells treated with THC for 24, 48, and 72 hours. The cells were divided into a control group (0 μmol/L THC) and six THC treatment groups (20, 40, 60, 80, 100, and 120 μM). Data are presented as the mean ± SD, n = 3. Compared to the control group, aP < 0.05; bP < 0.01; THC: Tetrahydrocurcumin.
- Citation: Bao ZC, Zhang Y, Liu ZD, Dai HJ, Ren F, Li N, Lv SY, Zhang Y. Tetrahydrocurcumin-induced apoptosis of hepatocellular carcinoma cells involves the TP53 signaling pathway, as determined by network pharmacology. World J Gastrointest Oncol 2025; 17(3): 101174
- URL: https://www.wjgnet.com/1948-5204/full/v17/i3/101174.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i3.101174